Sensus Healthcare (SRTS) Moves 19.9% Higher: Will This Strength Last?

Sensus Healthcare, Inc. SRTS shares rallied 19.9% in the last trading session to close at $8.24. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 3.2% loss over the past four weeks.Sensus Healthcare recorded a strong price rise on investors’ optimism surrounding the company’s impending fourth quarter and full year 2024 financial results, which is slated to release on Feb. 5. The Zacks Consensus Estimate for 2024 revenue suggests a growth of 58.1%. The company’s earnings is expected to grow to 41 cents per share compared with the 2023 figure. This company is expected to post quarterly earnings of $0.10 per share in its upcoming report, which represents a year-over-year change of -61.5%. Revenues are expected to be $9.86 million, down 21.6% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For Sensus Healthcare, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on SRTS going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Sensus Healthcare is part of the Zacks Medical - Instruments industry. Artivion AORT, another stock in the same industry, closed the last trading session 1.3% lower at $30.96. AORT has returned 11.7% in the past month.Artivion's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.12. Compared to the company's year-ago EPS, this represents a change of +9.1%. Artivion currently boasts a Zacks Rank of #3 (Hold).Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Sensus Healthcare, Inc. (SRTS): Free Stock Analysis Report Artivion, Inc. (AORT): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks